Correlation Between Iovance Biotherapeutics and TG Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and TG Therapeutics, you can compare the effects of market volatilities on Iovance Biotherapeutics and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and TG Therapeutics.

Diversification Opportunities for Iovance Biotherapeutics and TG Therapeutics

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Iovance and TGTX is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and TG Therapeutics go up and down completely randomly.

Pair Corralation between Iovance Biotherapeutics and TG Therapeutics

Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the TG Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Iovance Biotherapeutics is 1.05 times less risky than TG Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The TG Therapeutics is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest  2,571  in TG Therapeutics on August 30, 2024 and sell it today you would earn a total of  929.00  from holding TG Therapeutics or generate 36.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Iovance Biotherapeutics  vs.  TG Therapeutics

 Performance 
       Timeline  
Iovance Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Iovance Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
TG Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Iovance Biotherapeutics and TG Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Iovance Biotherapeutics and TG Therapeutics

The main advantage of trading using opposite Iovance Biotherapeutics and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.
The idea behind Iovance Biotherapeutics and TG Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon